Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Crohn's & Colitis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption: Results From the OCTAVE Clinical Trials
J Crohns Colitis 2021 Apr 22;[EPub Ahead of Print], J Panés, S Vermeire, MC Dubinsky, EV Loftus, N Lawendy, W Wang, L Salese, C Su, I Modesto, X Guo, J ColombelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.